Aesica Expands Oral Solids Capability at German Facility - - BioPharm International

ADVERTISEMENT

Aesica Expands Oral Solids Capability at German Facility



Aesica Pharmaceuticals, a CDMO, is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany.

The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.

Source: Aesica Pharmaceuticals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here